CHARACTER
Live / Registered — Registered (as of 11 Aug 2026)
What this means for you
Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 97352105
- Registration number
- 8392830
- Mark type
- Design + words
- Filed
- 07 Apr 2022
- Published for opposition
- 23 May 2023
- Registered
- 11 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 11 Aug 2032 (grace period to 11 Feb 2033)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
- Class 044 — Medical, beauty and agricultural services: Providing health information
Owner
- Clover Therapeutics Company, Jersey City, NJ, US
- Clover Therapeutics Company, Jersey City, NJ, US
- Clover Therapeutics Company, Jersey City, NJ, US
Prosecution history
- 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jul 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Jul 2026 — USE AMENDMENT FILED
- 20 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 11 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2026 — SOU EXTENSION 5 GRANTED
- 15 Jan 2026 — SOU EXTENSION 5 FILED
- 10 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2025 — SOU EXTENSION 4 GRANTED
- 14 Jul 2025 — SOU EXTENSION 4 FILED